Ibrance vs Trikafta
Side-by-side drug price comparison from Medicare Part D data
Verdict
Ibrance costs 22% less per claim than Trikafta ($10816.00 vs $13935.00). Ibrance has a generic alternative available. Total Medicare spending: Ibrance at $4.5B vs Trikafta at $3.5B.
| Metric | Ibrance | Trikafta |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $10,816* | $13,935 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $4.5B | $3.5B |
| Total Claims | 418,000 | 248,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -5.6%* | 18.4% |
| Generic Available | Yes | Yes |
| Condition | Cancer | Cystic Fibrosis |
| Total Beneficiaries | 36,000 | 18,000 |
Ibrance costs 22% less per claim than Trikafta ($10816.00 vs $13935.00). Ibrance has a generic alternative available. Total Medicare spending: Ibrance at $4.5B vs Trikafta at $3.5B.